WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,56 US$
arrow_upward
+0,48%(+0,060) 1D
16. 10., 16:00:00 GMT-4 · USD
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro WXXWY…
Otevřít
12,29 US$
Max.
12,56 US$
Min.
12,20 US$
Trž. kap.
198,43 mld.
Prům. obj.
61,89 tis.
Objem
110,85 tis.
52týd. max.
14,80 US$
52týd. min.
7,30 US$
Beta
0,01
Akcie v oběhu
2,06 mld.
Počet zaměstnanců
15 tis.
Otevřít
12,29 US$
Max.
12,56 US$
Min.
12,20 US$
Trž. kap.
198,43 mld.
Prům. obj.
61,89 tis.
Objem
110,85 tis.
52týd. max.
14,80 US$
52týd. min.
7,30 US$
Beta
0,01
Akcie v oběhu
2,06 mld.
Počet zaměstnanců
15 tis.
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
GlobeNewswire
·
před 24 minutami
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Nasdaq
·
před 9 minutami
Chartstopper: October 16, 2026
MarketWatch
·
před 41 minutami
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Investor's Business Daily
·
před 31 minutami
Dow Jones Futures: S&P 500, Nasdaq Break Key Levels As CoreWeave, Dell Dive; Tesla, SpaceX, Meta Loom
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Informace o Wuxi Biologics Cayman ADR